Tumors arising from certain CD1d+ cell types, such as some B cell lymphomas, commonly retain CD1d expression, though levels may vary with tumor stage, for example, declining during progression in multiple myeloma (74). Here, CD1D is linked to B-cell non-Hodgkin lymphoma.